This inventor holds 2 USPTO granted patents. Top assignees: Smithkline Beecham Corporation, University of Alberta. Active years: 2005-2008.
Company Filing History:
2 out of 2,198 
2 out of 454 
Years Active: 2005-2008
Title: Roy Henry Mosher: Innovator in Bacterial Genetics
Introduction
Roy Henry Mosher is a notable inventor based in Staten Island, NY (US). He has made significant contributions to the field of bacterial genetics, particularly in the production of clavulanic acid. With a total of 2 patents, his work has had a meaningful impact on biotechnology.
Latest Patents
Mosher's latest patents include innovative developments in bacterial genes and microorganisms. One of his key patents focuses on novel bacterial genes, microorganisms, and processes for improving the manufacture of 5R clavams, such as clavulanic acid. Additionally, he has isolated DNA that comprises one or more genes specific for 5S clavam biosynthesis, along with vectors that include such DNA and streptomyces hosts capable of enhanced clavulanic acid production.
Career Highlights
Throughout his career, Mosher has worked with prominent organizations, including SmithKline Beecham Corporation and the University of Alberta. His experience in these institutions has allowed him to advance his research and contribute to significant scientific advancements.
Collaborations
Some of his notable coworkers include John Patrick Griffin and Susan E. Jensen. Their collaborative efforts have further enriched the research landscape in which Mosher operates.
Conclusion
Roy Henry Mosher's contributions to bacterial genetics and his innovative patents highlight his role as a key figure in biotechnology. His work continues to influence the field and pave the way for future advancements.